US 10030024
Imidazopyridazines useful as inhibitors of the PAR-2 signaling pathway
granted A61PA61P1/02A61P1/04
Quick answer
US patent 10030024 (Imidazopyridazines useful as inhibitors of the PAR-2 signaling pathway) held by Vertex Pharmaceuticals Incorporated expires Mon Jul 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Jul 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61P, A61P1/02, A61P1/04, A61P11/06, A61P17/00